West Pharmaceutical Services Inc
WST- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000105770
In the last 90 days, West Pharmaceutical Services Inc insiders filed 0 open-market purchases and 2 sales; 834 institutions reported holding it in 13F filings for Q2 2026, worth $25.2B in total; Gates Foundation Trust is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding West Pharmaceutical Services Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 733 | 10 | 758 | +35 |
| Shares | 70.0M | 944.5K | 68.8M | −323.3K (−0.5%) |
| Value | $15.3B | $206.7M | $18.0B | +$2.90B (+19.3%) |
10 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (119)
Institutions that held West Pharmaceutical Services Inc at the end of Q3 2025 but not at the end of Q2 2025.
Showing the largest 100 of 119 by value.
Sold out (84)
Institutions that held West Pharmaceutical Services Inc at the end of Q2 2025 and filed for Q3 2025 without it.
Not filed for Q3 2025 yet (10)
Institutions that held West Pharmaceutical Services Inc at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 917,792 | $200.8M |
| CIBC World Markets Corp | 9,057 | $1.98M |
| Avantax Advisory Services, Inc. | 7,406 | $1.62M |
| Scott Marsh Financial, LLC | 5,906 | $1.29M |
| Congress Wealth Management LLC | 1,592 | $348.5K |
| E Fund Management Co., Ltd. | 1,343 | $293.8K |
| Atria Wealth Solutions, Inc. | 1,123 | $246.0K |
| First Horizon Advisors, Inc. | 207 | $45.5K |
| Centricity Wealth Management, LLC | 106 | $23.2K |
| Parkworth Wealth Management, Inc. | 1 | $219 |